Rothwell, Figg, Ernst & Manbeck, PC

Firm logo for Rothwell, Figg, Ernst & Manbeck, PC

Litigation Spotlight: The Epoetin alfa (Epogen®) Litigation

06/06/2017 The Amgen, Inc. and Amgen Manufacturing, Limited (“Amgen”) litigation against Hospira, Inc. (“Hospira”), filed in September 2015, was one…

Fake LinkedIn Accounts - What to Do and What LinkedIn is Doing

08/09/2020 On Wednesday, September 9, 2020, Wayne Farms LLC, an entity engaged in processing, packing, and otherwise selling a variety of food products in the…

USPTO Requests Comments on Patenting Artificial Intelligence Inventions

10/09/2019 On August 22, 2019, the United States Patent and Trademark Office (USPTO) published a request for comments on patenting artificial intelligence…

Celltrion’s and Hospira’s Production of Infliximab Biosimilars Does Not Infringe Remicide®-Related Patent

20/08/2018 In a 104-page ruling, U.S. District Judge Mark L. Wolf granted summary judgment in favor of Celltrion and Hospira, finding that a doctrine of…

World Intellectual Property Organization Weighs in on Artificial Intelligence and Intellectual Property

19/12/2019 Following on the heels of the United States Patent and Trademark Office’s request for comments, the World Intellectual Property Organization (WIPO)…

See more articles

Rothwell, Figg, Ernst & Manbeck, PC


  • USA

    • Washington DC

      607 14th Street North West, Suite 800, Washington DC 20005, USA
      T +1 202 783 6040F +1 202 783 6031[email protected]
    • Boston MA

      One Boston Place, Suite 2600, Boston MA, USA
      T 1 617 312 3101[email protected]
    • Ossining NY

      The Holyoke-Manhattan Building, 80 South Highland Avenue, Ossining NY 10562, USA
      T +1 914 941 5668